Fusion-Negative Alveolar Rhabdomyosarcoma: Clinical Trials

1 trial for Fusion-Negative Alveolar Rhabdomyosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Fusion-Negative Alveolar Rhabdomyosarcoma: new trials by email Literature Review of Fusion-Negative Alveolar Rhabdomyosarcoma trials Research Report on Fusion-Negative Alveolar Rhabdomyosarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Biopsy Procedure, Bone Scan, Computed Tomography - Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group2052022-08-042026-08-25

Narrower conditions

Rhabdomyosarcoma, Embryonal (1)

Broader conditions

Myosarcoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Muscle Tissue (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)

Interventions

Biopsy (1)  ·  Cyclophosphamide (1)  ·  Dactinomycin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Vincristine (1)

Sponsors

Children's Oncology Group (1)

Countries

Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  United States (1)

Top investigators

Josephine H Haduong (1)

NIH funding

U10CA180886 (1)